SMC
NDRM

S. Muoio & Co’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

S. Muoio & Co’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-87,950
Closed -$3.42M – 106
2017
Q3 		$3.42M Buy
+87,950
New +$3.24M 1.77% 16

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

S. Muoio & Co's NDRM Position: Q4 2017 in Review

S. Muoio & Co sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 87,950 shares — an estimated $3.42M sold.

S. Muoio & Co first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $3.42M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • S. Muoio & Co reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • S. Muoio & Co sold 87,950 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $3.42M.
  • S. Muoio & Co first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • S. Muoio & Co's NeuroDerm Ltd. Ordinary Shares position peaked at $3.42M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on S. Muoio & Co's 13F filing for Q4 2017, filed 9 Feb 2018.